American Portfolios Advisors Exact Sciences Corp Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Exact Sciences Corp stock. As of the latest transaction made, American Portfolios Advisors holds 17,284 shares of EXAS stock, worth $730,249. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,284
Holding current value
$730,249
% of portfolio
0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$31.97 - $49.37 $552,569 - $853,311
17,284 New
17,284 $562 Million
Q2 2022

Mar 20, 2023
SELL
$35.61 - $76.23 $427 - $914
-12 Reduced 0.07%
17,272 $680 Million
Q1 2022

Mar 21, 2023
BUY
$57.56 - $82.54 $7,367 - $10,565
128 Added 0.74%
17,412 $1.22 Billion
Q4 2021

Mar 21, 2023
SELL
$72.5 - $100.68 $168,925 - $234,584
-2,330 Reduced 13.48%
14,954 $1.16 Billion
Q3 2021

Mar 22, 2023
SELL
$90.24 - $124.05 $450,117 - $618,761
-4,988 Reduced 28.86%
12,296 $1.17 Billion
Q2 2021

Mar 22, 2023
SELL
$93.66 - $139.27 $565,612 - $841,051
-6,039 Reduced 34.94%
11,245 $1.4 Billion
Q1 2021

Mar 22, 2023
SELL
$116.57 - $155.01 $1.16 Million - $1.54 Million
-9,912 Reduced 57.35%
7,372 $971 Million
Q4 2020

Mar 22, 2023
SELL
$99.61 - $142.12 $1.2 Million - $1.72 Million
-12,087 Reduced 69.93%
5,197 $689 Million
Q3 2020

Mar 22, 2023
SELL
$72.92 - $102.01 $1.21 Million - $1.7 Million
-16,629 Reduced 96.21%
655 $66.8 Million
Q1 2020

Mar 24, 2023
SELL
$37.9 - $104.44 $630,959 - $1.74 Million
-16,648 Reduced 96.32%
636 $36.9 Million
Q4 2019

Mar 24, 2023
SELL
$77.66 - $99.74 $1.31 Million - $1.68 Million
-16,830 Reduced 97.37%
454 $42 Million
Q3 2019

Mar 24, 2023
SELL
$90.37 - $122.49 $1.56 Million - $2.11 Million
-17,254 Reduced 99.83%
30 $2.71 Million

Others Institutions Holding EXAS

# of Institutions
699
Shares Held
160M
Call Options Held
5.84M
Put Options Held
2.58M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.48B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email